SEC Form 20-F filed by Adagene Inc.

3/24/25 8:05:35 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Unavailable

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ADAG

Date	Price Target	Rating	Analyst
1/31/2025		Overweight → Equal-Weight	Morgan Stanley
2/1/2022	$27.00 → $15.00	Overweight	Morgan Stanley